What's going on in today's after hours session
By Mill Chart
Last update: Apr 3, 2024
These stocks are moving in today's after hours session
After hours gainers
| Ticker | Change | Comment |
|---|---|---|
| RELI | 58.11% | RELIANCE GLOBAL GROUP INC's (NASDAQ:RELI) shares rose 58.11% to $0.58 during Wednesday's after hours session. The stock is trading 26.83% lower than a month ago. |
| IMCC | 15.9% | Positive after-hours movement for IM CANNABIS CORP (NASDAQ:IMCC) as its shares recorded a 15.9% increase, reaching $1.13 during Wednesday's after-hours session. The positive market sentiment seen in today's regular session, where NASDAQ:IMCC closed with a 28.79% gain, carries over into the after-hours session. |
| BRBS | 14.86% | BLUE RIDGE BANKSHARES INC's (NYSEARCA:BRBS) stock price is advancing with 14.86% to a price of $3.17. Shareholders saw the stock price going 33.33% lower is the past 6 months. |
| ADBE | 13.88% | ADOBE INC (NASDAQ:ADBE) exhibits strong performance after hours, with shares rising 13.88% to $566.0 during Wednesday's after-hours session. The stock is trading 30.59% higher than a year ago. |
| MVLA | 12.85% | MOVELLA HOLDINGS INC's (NASDAQ:MVLA) shares rose 12.85% to $0.06. Following a -15.22% loss in the regular session, NASDAQ:MVLA is displaying signs of recovery during the after-hours session. |
| SLNA | 10.68% | After the regular session, SELINA HOSPITALITY PLC (NASDAQ:SLNA) continues to impress in the after-hours session, with a 10.68% increase to $0.11. Only today these shares were declining by -10.64%, so we see a bit of recovery during the after hours session. |
| IGC | 8.51% | In the after-hours session on Wednesday, IGC PHARMA INC (NYSEARCA:IGC) experienced a notable 8.51% increase, driving its shares to $0.69. The strong performance observed in the regular session, where NYSEARCA:IGC registered a 19.59% gain, continues to drive positive movement in the after-hours session. |
| MDIA | 8.4% | MEDIACO HOLDING INC-CL A's (NASDAQ:MDIA) stock price is advancing with 8.4% to a price of $1.42. Today's gain of 52.33% continues in today's after hours session with 8.4%. |
| HWH | 8.28% | After the closing bell, HWH INTERNATIONAL INC (NASDAQ:HWH) demonstrated strong momentum in the after-hours session, with a 8.28% rise to $1.7. In the last month the stock gained 57.0%. |
| BROG | 7.33% | BROOGE ENERGY LTD (NASDAQ:BROG) exhibits strong performance after hours, with shares rising 7.33% to $2.03 during Wednesday's after-hours session. Amidst today's -12.9% decline, we observe signs of recovery during the after-hours session for NASDAQ:BROG. Earlier today the company had a press release: SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Brooge. |
To see the full list of after hours gainers you can use our after hours gainers page.
Today's after hours losers
| Ticker | Change | Comment |
|---|---|---|
| ONTX | -9.45% | Today's after-hours session sees a continuation of the %ABSPERF% decrease earlier in the day for NASDAQ:ONTX. Two days ago the company had a press release: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company. |
| JZXN | -9.4% | JIUZI HOLDINGS INC's (NASDAQ:JZXN) shares fell 9.4% to $1.35. Price volatility persists as NASDAQ:JZXN closed the regular session -60.27% lower, and the downward trend carries on during the after-hours session. |
| VIEW | -5.9% | VIEW INC's (NASDAQ:VIEW) shares fell 5.9% to $0.48. NASDAQ:VIEW had a challenging day, closing -53.64% lower during the regular session, and the downward trend continues in the after-hours session. Yesterday the company had a press release: View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company. |
| EGOX | -5.31% | Following a 30.38% loss in the regular session, NASDAQ:EGOX exhibits further decline during today's after-hours session. Despite a significant 30.38% gain earlier today, NASDAQ:EGOX faces a reversal and declines in the after-hours session. |
| ONMD | -4.72% | ONEMEDNET CORP's (NASDAQ:ONMD) shares experienced a 4.72% decrease to $1.01 in the after-hours session. After running up 34.13% in today's session, NASDAQ:ONMD is pulling back after hours. Yesterday the company had a press release: OneMedNet Completes Securities Purchase Agreement, Solidifying Cash Position to Accelerate Growth. |
| KURA | -4.21% | KURA ONCOLOGY INC's (NASDAQ:KURA) stock price saw a decrease of 4.21% to $19.48 during Wednesday's after-hours session. In the last 3 months the share price increased with 35.6%. |
| ANGH | -4.0% | ANGHAMI INC's (NASDAQ:ANGH) stock price decreased by 4.0% to $0.96. Following a -44.44% loss in the regular session, NASDAQ:ANGH sees no respite as the after-hours session continues the downward trajectory. |
| AISP | -3.91% | AIRSHIP AI HOLDINGS INC's (NASDAQ:AISP) stock price is declining with 3.91% to a price of $10.56. After a notable 22.93% increase earlier today, NASDAQ:AISP shows signs of a pullback during the after-hours session. |
| SMFL | -3.85% | SMART FOR LIFE INC's (NASDAQ:SMFL) shares fell 3.85% to $0.52 during Wednesday's after hours session. In the last month the stock lost 41.23%. |
| EZGO | -3.8% | EZGO TECHNOLOGIES LTD's (NASDAQ:EZGO) stock price decreased by 3.8% to $0.06. In the last month the stock lost 32.12%. |
To see the full list of after hours losers you can use our after hours losers page.
KURA ONCOLOGY INC
NASDAQ:KURA (5/2/2024, 8:56:23 AM)
20.15
-0.13 (-0.64%)
KURA News
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the...
– Ziftomenib is the first investigational treatment to be granted Breakthrough Therapy Designation for NPM1-mutant AML – – Registration-directed trial of...
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the...
SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to...
– Company anticipates dosing of KO-2806 in combination with adagrasib in KRASG12C-mutant NSCLC next quarter – – Dose escalation of KO-2806 as a...
SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to...
2 months ago - Seeking AlphaKura Oncology GAAP EPS of -$0.55 in-line (NASDAQ:KURA)Kura Oncology reported Q4 2023 financial results, stating a GAAP EPS of -$0.55.
– Positive preliminary combination data from KOMET-007 trial of ziftomenib in NPM1-m and KMT2A-r AML, including effective mitigation of differentiation...
– KOMET-008 is evaluating ziftomenib in combination with gilteritinib, FLAG-IDA or LDAC in patients with relapsed/refractory NPM1-mutant or...
SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the...
SAN DIEGO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the...
3 months ago - Seeking AlphaKura Oncology files to sell 8.7M shares for its holders (NASDAQ:KURA)Kura Oncology files prospectus for resale of 8.7 million common shares, clarifying it is not an offer to sell securities.
